Skip to content
Review Open access

Management of plexiform neurofibromas in neurofibromatosis type 1: An Italian Delphi consensus

Sep 2026 · Neurological Sciences · Vol 47 · 0 citations · 63 references
Medicine

TL;DR

An evidence-informed and clinically oriented framework for management of NF1-associated PNs is provided, complementary to existing international recommendations, and offers practical guidance in areas where evidence remains limited.

Abstract

Plexiform neurofibromas (PNs) are among the most complex and challenging manifestations of neurofibromatosis type 1 (NF1). Recent advances in understanding their epidemiology, natural history, biology, and imaging features, together with the introduction of MEK inhibitors, have significantly reshaped clinical management. Despite availability of international recommendations for tumor surveillance in NF1, several aspects of PN management remain incompletely defined in clinical practice. A multidisciplinary panel of 17 Italian NF1 experts conducted a Real-Time Delphi consensus process including a literature review, thematic analysis, and development of consensus statements. Key domains encompassed diagnosis, imaging assessment, surveillance, surgical evaluation, multidisciplinary management, and treatment of PNs. Two rounds of voting were conducted through a dedicated online platform, ensuring anonymity, real-time feedback, and iterative refinement of the statements. Consensus was achieved on 49 final statements. Key recommendations emphasized the importance of early identification of PNs, assessment of internal tumor burden through whole-body MRI, standardized imaging acquisition and reporting, timely recognition and characterization of distinct nodular lesions, and implementation of risk-adapted surveillance strategies. The panel also underscored the importance of patient education regarding signs suggestive of malignant transformation, and recommended a structured multidisciplinary approach to clinical decision-making. Agreement was additionally reached on practical aspects including radiological follow-up, criteria for surgical referral, definitions of PN-related symptoms, inoperability, and integration of surgical and targeted treatment strategies. This national consensus provides an evidence-informed and clinically oriented framework for management of NF1-associated PNs. Complementing existing international recommendations, it offers practical guidance in areas where evidence remains limited. Early diagnosis of Plexiform Neurofibromas (PNs) in patients with Neurofibromatosis type 1 (NF1) is essential to optimize surveillance and therapeutic decision-making. Whole-body MRI at transition to adulthood is useful for assessing internal tumor burden and guiding risk-adapted management strategies. Distinct nodular lesions should be accurately reported in MRI reports and require dedicated multidisciplinary assessment and follow-up. Patient education is a fundamental component of PN management and supports early recognition of disease progression. Multidisciplinary team evaluation is essential for the management of complex, symptomatic or potentially symptomatic PNs. Surgery and MEK inhibitors should be considered complementary therapeutic strategies within a multidisciplinary framework. This national multidisciplinary consensus provides practical recommendations to support clinical decision-making in NF1-associated PNs. Early diagnosis of Plexiform Neurofibromas (PNs) in patients with Neurofibromatosis type 1 (NF1) is essential to optimize surveillance and therapeutic decision-making. Whole-body MRI at transition to adulthood is useful for assessing internal tumor burden and guiding risk-adapted management strategies. Distinct nodular lesions should be accurately reported in MRI reports and require dedicated multidisciplinary assessment and follow-up. Patient education is a fundamental component of PN management and supports early recognition of disease progression. Multidisciplinary team evaluation is essential for the management of complex, symptomatic or potentially symptomatic PNs. Surgery and MEK inhibitors should be considered complementary therapeutic strategies within a multidisciplinary framework. This national multidisciplinary consensus provides practical recommendations to support clinical decision-making in NF1-associated PNs.

Read PDF

Similar papers

Review Open access Sep 2026

Recommendations for the diagnosis and management of neurofibromatosis type 1 in Singapore: A Delphi consensus.

Introduction Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder with wide phenotypic variability, necessitating coordinated multidisciplinary care and Singapore-relevant guidance. This study aimed to develop Singapore-specific, consensus-based recommendations for NF1 diagnosis, surveillance, and managemen...

Nikki Fong, Ee-Shi-En Tan, J. Ngeow et al. · 1 citation
Review Open access Aug 2026

Neurofibromatosis Type I: Consensus on Current Terminology for Neurofibromas, as a Basis for Recommendations on the Use of MEK Inhibitors

Experts from the German NF Working Group sought to harmonize current terminology for NF1-associated neurofibromas, with particular emphasis on PNF, and to relate this terminology to diagnostic procedures, clinical course, and treatment considerations, and a new structured terminology of NF integrating anatomic and hist...

L. Baldino, J. Koeppen, Josef Kammermeier et al. · 0 citations
Open access Aug 2026

Clinical Management and Therapeutic Advances in Pediatric Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

While surgical boundaries remain highly restricted in deep-tissue infiltrative PN, the introduction of targeted MEK inhibitors marks a pivotal therapeutic paradigm shift and improving timely access to these therapies may help prevent further functional deterioration in selected pediatric patients.

Karina Quintero, Lorelay Cárcamo, Andrés Bernales et al. · 0 citations
Open access Aug 2026

Cherry Angiomas in Individuals With Neurofibromatosis Type 1.

The results of this cross-sectional study suggest that CAs represent a frequent and previously unrecognized vascular manifestation of NF1, which is supported by epidemiological enrichment and mechanistic evidence of biallelic NF1 inactivation in vascular cells.

L. Fertitta, É. Pasmant, C. Bergqvist et al. · 0 citations
Open access Aug 2026

Retroperitoneal Manifestations of Type 1 Neurofibromatosis: A Case Report

Type 1 neurofibromatosis (NF1) is a common autosomal dominant genetic disorder characterized by various manifestations, including plexiform neurofibromas; retroperitoneal involvement is rare but can complicate diagnosis and management. We report the case of a 42-year-old man presenting with pelvic pain and a left glute...

A. Elmoctar, M. Ouazine, H. Bello et al. · 0 citations
Review Oct 2026

International Modified Delphi Consensus on Assessment and Management of Covert Brain Infarction.

BackgroundCovert brain infarction (CBI) is a frequent incidental neuroradiological finding increasingly recognized as clinically relevant due to its association with stroke, cognitive decline, and other adverse outcomes. However, substantial uncertainty remains regarding its optimal assessment and management, and exist...

B. K. Vitturi, Terence J. Quinn, G. Thomalla et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.